181 related articles for article (PubMed ID: 36201445)
21. Imaging of changes in copper trafficking and redistribution in a mouse model of Niemann-Pick C disease using positron emission tomography.
Baguña Torres J; Yu Z; Bordoloi J; Sunassee K; Smith D; Smith C; Chen O; Purchase R; Tuschl K; Spencer J; Platt F; Blower PJ
Biometals; 2019 Apr; 32(2):293-306. PubMed ID: 30847690
[TBL] [Abstract][Full Text] [Related]
22. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
23. Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.
Fletcher JW; Logan TF; Eitel JA; Mathias CJ; Ng Y; Lacy JL; Hutchins GD; Green MA
J Nucl Med; 2015 Jan; 56(1):56-62. PubMed ID: 25525184
[TBL] [Abstract][Full Text] [Related]
24. Imaging niacin trafficking with positron emission tomography reveals in vivo monocarboxylate transporter distribution.
Bongarzone S; Barbon E; Ferocino A; Alsulaimani L; Dunn J; Kim J; Sunassee K; Gee A
Nucl Med Biol; 2020; 88-89():24-33. PubMed ID: 32683248
[TBL] [Abstract][Full Text] [Related]
25. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
[TBL] [Abstract][Full Text] [Related]
26.
Suilamo S; Li XG; Lankinen P; Oikonen V; Tolvanen T; Luoto P; Viitanen R; Saraste A; Seppänen M; Pirilä L; Hohenthal U; Roivainen A
J Nucl Med; 2022 Oct; 63(10):1598-1603. PubMed ID: 35273093
[No Abstract] [Full Text] [Related]
27. PET imaging analysis with 64Cu in disulfiram treatment for aberrant copper biodistribution in Menkes disease mouse model.
Nomura S; Nozaki S; Hamazaki T; Takeda T; Ninomiya E; Kudo S; Hayashinaka E; Wada Y; Hiroki T; Fujisawa C; Kodama H; Shintaku H; Watanabe Y
J Nucl Med; 2014 May; 55(5):845-51. PubMed ID: 24627433
[TBL] [Abstract][Full Text] [Related]
28. New calculation of excitation functions of proton-induced reactions in some medical isotopes of Cu, Zn and Ga.
Aydin A; Sarer B; Tel E
Appl Radiat Isot; 2007 Mar; 65(3):365-70. PubMed ID: 17142050
[TBL] [Abstract][Full Text] [Related]
29. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
30. Quantification of regional myocardial perfusion with generator-produced 62Cu-PTSM and positron emission tomography.
Herrero P; Markham J; Weinheimer CJ; Anderson CJ; Welch MJ; Green MA; Bergmann SR
Circulation; 1993 Jan; 87(1):173-83. PubMed ID: 8419005
[TBL] [Abstract][Full Text] [Related]
31. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.
Okazawa H; Yonekura Y; Fujibayashi Y; Nishizawa S; Magata Y; Ishizu K; Tanaka F; Tsuchida T; Tamaki N; Konishi J
J Nucl Med; 1994 Dec; 35(12):1910-5. PubMed ID: 7989968
[TBL] [Abstract][Full Text] [Related]
32. Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography.
Shelton ME; Green MA; Mathias CJ; Welch MJ; Bergmann SR
Circulation; 1990 Sep; 82(3):990-7. PubMed ID: 2394015
[TBL] [Abstract][Full Text] [Related]
33. Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders.
Emilie Munk D; Teicher Kirk F; Vendelbo M; Vase K; Munk O; Ott P; Damgaard Sandahl T
J Vis Exp; 2023 Apr; (194):. PubMed ID: 37184248
[TBL] [Abstract][Full Text] [Related]
34. Performance of a ⁶²Zn/⁶²Cu microgenerator in kit-based synthesis and delivery of [⁶²Cu]Cu-ETS for PET perfusion imaging.
Ng Y; Lacy JL; Fletcher JW; Green MA
Appl Radiat Isot; 2014 Sep; 91():38-43. PubMed ID: 24886964
[TBL] [Abstract][Full Text] [Related]
35. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
36. In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue.
Griessinger CM; Kehlbach R; Bukala D; Wiehr S; Bantleon R; Cay F; Schmid A; Braumüller H; Fehrenbacher B; Schaller M; Eichner M; Sutcliffe JL; Ehrlichmann W; Eibl O; Reischl G; Cherry SR; Röcken M; Pichler BJ; Kneilling M
J Nucl Med; 2014 Feb; 55(2):301-7. PubMed ID: 24434289
[TBL] [Abstract][Full Text] [Related]
37. Preclinical evaluation of a
Jadvar H; Chen K; Park R; Yap LP; Vorobyova I; Swenson S; Markland FS
Amino Acids; 2019 Nov; 51(10-12):1569-1575. PubMed ID: 31621030
[TBL] [Abstract][Full Text] [Related]
38. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography.
Adonai N; Adonai N; Nguyen KN; Walsh J; Iyer M; Toyokuni T; Phelps ME; McCarthy T; McCarthy DW; Gambhir SS
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3030-5. PubMed ID: 11867752
[TBL] [Abstract][Full Text] [Related]
39. Insights into Trace Metal Metabolism in Health and Disease from PET: "PET Metallomics".
Bartnicka JJ; Blower PJ
J Nucl Med; 2018 Sep; 59(9):1355-1359. PubMed ID: 29976696
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]